BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38339005)

  • 1. Therapeutic Delivery of Soluble Fractalkine Ameliorates Vascular Dysfunction in the Diabetic Retina.
    Rodriguez D; Church KA; Smith CT; Vanegas D; Cardona SM; Muzzio IA; Nash KR; Cardona AE
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38339005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina.
    Rodriguez D; Church KA; Pietramale AN; Cardona SM; Vanegas D; Rorex C; Leary MC; Muzzio IA; Nash KR; Cardona AE
    J Neuroinflammation; 2024 Feb; 21(1):42. PubMed ID: 38311721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy.
    Mills SA; Jobling AI; Dixon MA; Bui BV; Vessey KA; Phipps JA; Greferath U; Venables G; Wong VHY; Wong CHY; He Z; Hui F; Young JC; Tonc J; Ivanova E; Sagdullaev BT; Fletcher EL
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34903661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
    Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
    ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1
    Church KA; Rodriguez D; Mendiola AS; Vanegas D; Gutierrez IL; Tamayo I; Amadu A; Velazquez P; Cardona SM; Gyoneva S; Cotleur AC; Ransohoff RM; Kaur T; Cardona AE
    Front Immunol; 2023; 14():1130735. PubMed ID: 37033925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy.
    Mendiola AS; Garza R; Cardona SM; Mythen SA; Lira SA; Akassoglou K; Cardona AE
    Front Cell Neurosci; 2016; 10():303. PubMed ID: 28119571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.
    Jiang M; Xie H; Zhang C; Wang T; Tian H; Lu L; Xu JY; Xu GT; Liu L; Zhang J
    J Cell Mol Med; 2022 Feb; 26(4):1229-1244. PubMed ID: 35023309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia.
    Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X
    Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice.
    Winter AN; Subbarayan MS; Grimmig B; Weesner JA; Moss L; Peters M; Weeber E; Nash K; Bickford PC
    J Neuroinflammation; 2020 May; 17(1):157. PubMed ID: 32410624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1.
    Finneran D; Li Q; Subbarayan MS; Joly-Amado A; Kamath S; Dengler DG; Gordon MN; Jackson MR; Morgan D; Bickford PC; Smith LH; Nash KR
    Glia; 2023 Feb; 71(2):245-258. PubMed ID: 36106533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.
    Clark AK; Yip PK; Malcangio M
    J Neurosci; 2009 May; 29(21):6945-54. PubMed ID: 19474321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of age and Cx3cr1 deficiency on retinal microglia in the Ins2(Akita) diabetic mouse.
    Kezic JM; Chen X; Rakoczy EP; McMenamin PG
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):854-63. PubMed ID: 23307960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Maintains Inner Blood-Retinal Barrier by Regulating Microglia
    Tang L; Zhang C; Lu L; Tian H; Liu K; Luo D; Qiu Q; Xu GT; Zhang J
    Front Immunol; 2022; 13():831660. PubMed ID: 35371022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.
    Pfeifer CW; Walsh JT; Santeford A; Lin JB; Beatty WL; Terao R; Liu YA; Hase K; Ruzycki PA; Apte RS
    Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2308214120. PubMed ID: 37903272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.
    Zhao L; Ma W; Fariss RN; Wong WT
    Exp Eye Res; 2009 Jun; 88(6):1004-13. PubMed ID: 19176215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.
    Chen X; He X; Xu F; Xu N; Sharifi NH; Zhang P; Flores JJ; Wu L; He Q; Kanamaru H; Zhu S; Dong S; Han M; Yuan Y; Huang L; Miao L; Zhang JH; Zhou Y; Tang J
    Stroke; 2023 Sep; 54(9):2420-2433. PubMed ID: 37465997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.
    Roche SL; Wyse-Jackson AC; Gómez-Vicente V; Lax P; Ruiz-Lopez AM; Byrne AM; Cuenca N; Cotter TG
    PLoS One; 2016; 11(11):e0165197. PubMed ID: 27814376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migration.
    Zhang M; Xu G; Liu W; Ni Y; Zhou W
    PLoS One; 2012; 7(4):e35446. PubMed ID: 22536384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression.
    Noda M; Doi Y; Liang J; Kawanokuchi J; Sonobe Y; Takeuchi H; Mizuno T; Suzumura A
    J Biol Chem; 2011 Jan; 286(3):2308-19. PubMed ID: 21071446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model.
    Finneran DJ; Morgan D; Gordon MN; Nash KR
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):312-325. PubMed ID: 30499006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.